Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2008

Open Access 01-12-2008 | Research article

The statistical analysis of a clinical trial when a protocol amendment changed the inclusion criteria

Authors: Christian Lösch, Markus Neuhäuser

Published in: BMC Medical Research Methodology | Issue 1/2008

Login to get access

Abstract

Background

Sometimes, protocol amendments that change the inclusion and exclusion criteria are required in clinical trials. Then, the patient populations before and after the amendment may differ.

Methods

We propose to perform separate statistical tests for the different phases, i.e. for the patients recruited before and after the amendment, and to combine the tests using Fisher's combination test. After a significant combination test a multiple testing procedure can be applied to identify the phase(s) to which a proof of efficacy refers. We assume that the amendment(s) are not based on any type of unblinded data. The proposed method is investigated within a simulation study.

Results

The proposed combination approach is superior to the 'naïve' strategy to ignore the differences between the phases and pooling the data to perform just one statistical test. This superiority disappears when there are hardly any differences between the two phases.

Conclusion

When one or more protocol amendments change the inclusion and exclusion criteria, one should realize that the populations may differ. In this case, separate tests for the different phases together with a combination test are a powerful method that can be applied in a variety of settings. The (first) amendment should specify the combination test to be applied in order to combine the different phases.
Appendix
Available only for authorised users
Literature
1.
go back to reference ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med. 1999, 18: 1905-1942. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med. 1999, 18: 1905-1942.
2.
go back to reference Cleophas TJ, Zwinderman AH, Cleophas TF: Statistical Applied to Clinical Trials. 2006, Springer, third edition Cleophas TJ, Zwinderman AH, Cleophas TF: Statistical Applied to Clinical Trials. 2006, Springer, third edition
3.
go back to reference Chow SC, Shao J: Inference for clinical trials with some protocol amendments. J Biopharm Stat. 2005, 15: 659-666. 10.1081/BIP-200062286.CrossRefPubMed Chow SC, Shao J: Inference for clinical trials with some protocol amendments. J Biopharm Stat. 2005, 15: 659-666. 10.1081/BIP-200062286.CrossRefPubMed
4.
go back to reference Svolba G, Bauer P: Statistical quality control in clinical trials. Control Clin Trials. 1999, 20: 519-530. 10.1016/S0197-2456(99)00029-X.CrossRefPubMed Svolba G, Bauer P: Statistical quality control in clinical trials. Control Clin Trials. 1999, 20: 519-530. 10.1016/S0197-2456(99)00029-X.CrossRefPubMed
5.
go back to reference Dubertret L, Sterry W, Bos JD, Chimenti S, Shumack S, Larsen CG, Shear NH, Papp KA: Clinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol. 2006, 155: 170-181. 10.1111/j.1365-2133.2006.07344.x.CrossRefPubMed Dubertret L, Sterry W, Bos JD, Chimenti S, Shumack S, Larsen CG, Shear NH, Papp KA: Clinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol. 2006, 155: 170-181. 10.1111/j.1365-2133.2006.07344.x.CrossRefPubMed
6.
go back to reference Follmann DA: The effect of screening on some pretest-posttest test variances. Biometrics. 1991, 47: 763-771. 10.2307/2532164.CrossRefPubMed Follmann DA: The effect of screening on some pretest-posttest test variances. Biometrics. 1991, 47: 763-771. 10.2307/2532164.CrossRefPubMed
7.
go back to reference Loughin TM: A systematic comparison of methods for combining p-values from independent tests. Computational Statistics & Data Analysis. 2004, 47: 467-485. 10.1016/j.csda.2003.11.020.CrossRef Loughin TM: A systematic comparison of methods for combining p-values from independent tests. Computational Statistics & Data Analysis. 2004, 47: 467-485. 10.1016/j.csda.2003.11.020.CrossRef
8.
go back to reference Hedges LV, Olkin I: Statistical methods for meta-analysis. 1985, Boston, Academic Press,Inc. Hedges LV, Olkin I: Statistical methods for meta-analysis. 1985, Boston, Academic Press,Inc.
9.
go back to reference Bauer P, Kieser M: Combining different phases in the development of medical treatments within a single trial. Stat Med. 1999, 18: 1833-1848. 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO;2-3.CrossRefPubMed Bauer P, Kieser M: Combining different phases in the development of medical treatments within a single trial. Stat Med. 1999, 18: 1833-1848. 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO;2-3.CrossRefPubMed
10.
go back to reference Koch A: Confirmatory clinical trials with an adaptive design. Biom J. 2006, 48: 574-585. 10.1002/bimj.200510239.CrossRefPubMed Koch A: Confirmatory clinical trials with an adaptive design. Biom J. 2006, 48: 574-585. 10.1002/bimj.200510239.CrossRefPubMed
11.
12.
go back to reference Bauer P, Köhne K: Evaluation of experiments with adaptive interim analyses. Biometrics. 1994, 50: 1029-1041. 10.2307/2533441.CrossRefPubMed Bauer P, Köhne K: Evaluation of experiments with adaptive interim analyses. Biometrics. 1994, 50: 1029-1041. 10.2307/2533441.CrossRefPubMed
13.
go back to reference Banik N, Köhne K, Bauer P: On the power of Fisher's combination test for two stage sampling in the presence of nuisance parameters. Biometrical Journal. 1996, 38: 25-37. 10.1002/bimj.4710380103.CrossRef Banik N, Köhne K, Bauer P: On the power of Fisher's combination test for two stage sampling in the presence of nuisance parameters. Biometrical Journal. 1996, 38: 25-37. 10.1002/bimj.4710380103.CrossRef
14.
go back to reference Müller HH, Schäfer H: A general statistical principle for changing a design any time during the course of a trial. Stat Med. 2004, 23: 2497-2508. 10.1002/sim.1852.CrossRefPubMed Müller HH, Schäfer H: A general statistical principle for changing a design any time during the course of a trial. Stat Med. 2004, 23: 2497-2508. 10.1002/sim.1852.CrossRefPubMed
15.
go back to reference Brannath W, König F, Bauer P: Estimation in flexible two stage designs. Stat Med. 2006, 25: 3366-3381. 10.1002/sim.2258.CrossRefPubMed Brannath W, König F, Bauer P: Estimation in flexible two stage designs. Stat Med. 2006, 25: 3366-3381. 10.1002/sim.2258.CrossRefPubMed
Metadata
Title
The statistical analysis of a clinical trial when a protocol amendment changed the inclusion criteria
Authors
Christian Lösch
Markus Neuhäuser
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2008
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-8-16

Other articles of this Issue 1/2008

BMC Medical Research Methodology 1/2008 Go to the issue